ESSA Pharma Inc. Quarterly Deferred Tax Assets, Net of Valuation Allowance in USD from Q3 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
ESSA Pharma Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q3 2019 to Q3 2023.
  • ESSA Pharma Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending September 30, 2023 was $0.000.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $0 $0 Sep 30, 2023 10-K 2023-12-12
Q3 2022 $0 $0 Sep 30, 2022 10-K 2023-12-12
Q3 2021 $0 $0 Sep 30, 2021 10-K 2022-12-13
Q3 2020 $0 $0 Sep 30, 2020 10-K 2021-11-18
Q3 2019 $0 Sep 30, 2019 10-K 2020-12-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.